Grail Inc (GRAL)

Currency in USD
108.52
+0.55(+0.51%)
Closed·
109.38+0.86(+0.79%)
·
Unusual trading volume
GRAL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
104.00112.58
52 wk Range
41.50118.84
Key Statistics
Prev. Close
108.52
Open
106.75
Day's Range
104-112.58
52 wk Range
41.5-118.84
Volume
3.26M
Average Volume (3m)
779.34K
1-Year Change
130.9919%
Book Value / Share
59.25
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GRAL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
82.40
Downside
-24.07%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory

Grail Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

5 Buy
6 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 82.40
(-24.07% Downside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Baird
Buy118.00+8.74%96.00MaintainSep 22, 2026
RBC Capital
Hold84.00-22.59%-New CoverageSep 17, 2026
UBS
Buy105.00-3.24%-New CoverageSep 09, 2026
Baird
Buy86.00-20.75%77.00MaintainSep 03, 2026
Mizuho
Hold65.00-40.10%58.00MaintainJul 15, 2026

Grail Inc Earnings Call Summary for Q2/2026

  • GRAIL Q2 revenue hit $44.7M, beating estimates by 3.5% with 26% YoY growth; test volume surged 35% to 61,000 tests driven by screening sales.
  • Shares dropped 8.33% after-hours despite revenue beat as adjusted EBITDA loss widened to $90.3M from $78.4M YoY; net loss remained $110.2M.
  • Company expects FDA advisory committee meeting fall 2026 with potential approval in early 2027, viewed as critical catalyst for payer coverage.
  • Cash position stands at $861.6M including $110M Samsung investment; Illumina 7% royalty resumes Q4 2026, potentially impacting 2027 margins.
  • Management expanded sales force ahead of FDA decision; average test price fell to ~$700 due to strategic mix shift toward digital health partnerships.
Last Updated: 05/08/2026, 22:32
Read Full Transcript

Earnings

Latest Release
Aug 05, 2026
EPS / Forecast
-2.56 / --
Revenue / Forecast
44.7M / 43.2M
EPS Revisions
Last 90 days

GRAL Income Statement

Compare GRAL to Peers and Sector

Metrics to compare
GRAL
Peers
Sector
Relationship
P/E Ratio
−12.4x−16.2x−0.4x
PEG Ratio
−0.49−0.090.00
Price/Book
1.9x2.9x2.6x
Price / LTM Sales
29.3x19.7x3.1x
Upside (Analyst Target)
−23.7%2.6%52.9%
Fair Value Upside
Unlock−38.2%6.4%Unlock

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
12.35M27.64%1.33B
Other Institutional Investors
29.65M66.39%3.20B
Public Companies & Retail Investors
2.67M5.97%287.95M
Total
44.67M100.00%4.82B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Farallon Capital Management, L.L.C.9.32%4,161,584449,326
Baker Bros. Advisors LP9.02%4,028,614434,969

People Also Watch

945.67
LITE
-0.92%
192.56
CRDO
+2.82%
363.46
ALAB
+6.67%
195.37
SKHY
+3.45%
464.60
WDC
+3.67%

FAQ

What Is the Grail (GRAL) Stock Price Today?

The Grail stock price today is 108.52 USD.

What Stock Exchange Does Grail Trade On?

Grail is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Grail?

The stock symbol for Grail is "GRAL."

What Is the Grail (GRAL) Afterhours Price Today? (Afterhours variable test: 109.38) Current Date: Sep 23, 2026

After hours price: 109.38. After hours price change (units): 0.86. Price change percentage: 0.79%

What Is the Grail Market Cap?

As of today, Grail market cap is 4.85B USD.

What Is Grail's Earnings Per Share (TTM)?

The Grail EPS (TTM) is -9.75.

When Is the Next Grail Earnings Date?

Grail will release its next earnings report on Nov 18, 2026.

From a Technical Analysis Perspective, Is GRAL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Grail Stock Split?

Grail has split 0 times.

How Many Employees Does Grail Have?

Grail has 910 employees.

What is the current trading status of Grail (GRAL)?

As of Sep 23, 2026, Grail (GRAL) is trading at a price of 108.52 USD, with a previous close of 108.52 USD. The stock has fluctuated within a day range of 104.00 USD to 112.58 USD, while its 52-week range spans from 41.50 USD to 118.84 USD.

What Is Grail (GRAL) Price Target According to Analysts?

The average 12-month price target for Grail is 82.40 USD, with a high estimate of 118 USD and a low estimate of 60 USD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an -24.07% Downside potential.

What Is the GRAL Premarket Price?

GRAL's last pre-market stock price is 106.70 USD. The pre-market share volume is 14,780.00, and the stock has decreased by -1.27, or -1.18%.

What Is the GRAL After Hours Price?

GRAL's last after hours stock price is 109.38 USD, the stock has decreased by 0.86, or 0.79%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.